Home Other Building Blocks 113981-44-5
113981-44-5,MFCD00944908
Catalog No.:AA000A5Z

113981-44-5 | Cefozopran hydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$8.00   $6.00
- +
50mg
98%
in stock  
$41.00   $29.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000A5Z
Chemical Name:
Cefozopran hydrochloride
CAS Number:
113981-44-5
Molecular Formula:
C19H18ClN9O5S2
Molecular Weight:
551.9865
MDL Number:
MFCD00944908
SMILES:
CO/N=C(/c1nsc(n1)N)\C(=O)N[C@@H]1C(=O)N2[C@@H]1SCC(=C2C(=O)O)C[n+]1ccn2c1cccn2.[Cl-]
Properties
Computed Properties
 
Complexity:
965  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
1  
Heavy Atom Count:
36  
Hydrogen Bond Acceptor Count:
13  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
7  

Upstream Synthesis Route

[1]Patent:WO2010/89729,2010,A1,.Locationinpatent:Page/Pagecolumn25-26

Downstream Synthesis Route
cefozopran 
  113981-44-5 

[1]Patent:CN105153201,2017,B.Locationinpatent:Paragraph0017;0060;0066

[2]Patent:WO2010/89729,2010,A1.Locationinpatent:Page/Pagecolumn30

113981-44-5   
(6R,7R)-7-(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetylamino}-3-(imidazo1,2-bpyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylatehemihydrochloride 

[1]Patent:WO2010/89729,2010,A1.Locationinpatent:Page/Pagecolumn28

89604-91-1   
7β-amino-3-(imidazo1,2-bpyridazinium-1-yl)methyl-3-cephem-4-carboxylatehydrochloride 
  113981-44-5 

[1]Patent:WO2010/89729,2010,A1.Locationinpatent:Page/Pagecolumn25-26

(6R,7R)-7-(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetylamino}-3-(imidazo1,2-bpyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylatehemihydrochloride 
  113981-44-5 

[1]Patent:WO2010/89729,2010,A1.Locationinpatent:Page/Pagecolumn29

Literature

Title: Sato T, et al. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders. Pediatr Blood Cancer. 2008;51(6):774-777.

Title: Iizawa Y, et al. Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice. Antimicrob Agents Chemother. 1993;37(1):100-105.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 113981-44-5
Tags:113981-44-5 Molecular Formula|113981-44-5 MDL|113981-44-5 SMILES|113981-44-5 Cefozopran hydrochloride